Liraglutide in PCOS (LIPOS) Study: Evaluation of the Efficacy of Liraglutide on Menstrual Cyclicity in Women with PCOS - a prospective randomised double-blind placebo-controlled study
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Liraglutide (Primary) ; Metformin
- Indications Polycystic ovary syndrome
- Focus Therapeutic Use
- Acronyms LIPOS
- 19 Oct 2015 Accrual to date is 175% according to United Kingdom Clinical Research Network record.
- 19 Oct 2015 Planned End Date changed from 30 Jun 2015 to 31 Jul 2015 as reported by United Kingdom Clinical Research Network record.
- 19 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.